Blood Cancer Journal - Table of Contents alert Volume 4 July 2014

If you are unable to see the message below, click here to view.

Advertisement BD FACSCanto™ has 10-color capability.  Reliable performance, accuracy, and ease of use make the latest BD FACSCanto System a perfect 10 for today's busy clinical labs. Learn how you can achieve dependable outcomes while speeding workflow and reducing training requirements with clinical multi-color flow cytometry systems from BD Biosciences.  bdbiosciences.com/go/canto   TABLE OF CONTENTS Volume 4, July 2014 In this issue Original Articles Letters to the Editor Sign up for e-alerts Web feed Advertisement Blood Cancer Journal: submit your forthcoming research  Ensure wide visibility and global reach for your next piece of research - find out more about the benefits of submitting to Blood Cancer Journal here.   Original Articles Top Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia A Efanov, N Zanesi, V Coppola, G Nuovo, B Bolon, D Wernicle-Jameson, A Lagana, A Hansjuerg, F Pichiorri and C M Croce Blood Cancer J 2014 4: e227; 10.1038/bcj.2014.46 Abstract | Full Text Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group H Matsuo, M Kajihara, D Tomizawa, T Watanabe, A M Saito, J Fujimoto, K Horibe, K Kodama, M Tokumasu, H Itoh, H Nakayama, A Kinoshita, T Taga, A Tawa, T Taki, S Tanaka and S Adachi Blood Cancer J 2014 4: e226; 10.1038/bcj.2014.47 Abstract | Full Text The glutathione synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma A Tagde, H Singh, M H Kang and C P Reynolds Blood Cancer J 2014 4: e229; 10.1038/bcj.2014.45 Abstract | Full Text Letters to the Editor Top The stimulation of PD-L1-specific cytotoxic T lymphocytes can both directly and indirectly enhance antileukemic immunity S M Ahmad, I M Svane and M H Andersen Blood Cancer J 2014 4: e230; 10.1038/bcj.2014.50 Full Text Different molecular levels of post-induction minimal residual disease may predict hematopoietic stem cell transplantation outcome in adult Philadelphia-negative acute lymphoblastic leukemia R Bassan, O Spinelli, E Oldani, T Intermesoli, M Tosi, B Peruta, E Borlenghi, E M Pogliani, E Di Bona, V Cassibba, A M Scattolin, C Romani, F Ciceri, A Cortelezzi, G Gianfaldoni, D Mattei, E Audisio and A Rambaldi Blood Cancer J 2014 4: e225; 10.1038/bcj.2014.48 Full Text Effect of CAL-101, a PI3Kδ inhibitor, on ribosomal rna synthesis and cell proliferation in acute myeloid leukemia cells L X T Nguyen, A Sesay and B S Mitchell Blood Cancer J 2014 4: e228; 10.1038/bcj.2014.49 Full Text You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.